Both Semaglutide and Mounjaro represent new methods to treating type 2 diabetes, and increasingly, obesity. Semaglutide is a dual molecule that works on two chemicals involved in metabolism: this peptide and another incretin. It, often seen as a product name for this compound, functions similarly